Template:BV Antibiotics/es: Difference between revisions

(Created page with "====Embarazada====")
 
(Created page with "*Metronidazole 500mg VO Dos veces al día x 7 días<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref> *Metronidazole 250mg VO Tres veces al día también ha sido estudiado<ref name="Reduced incidence of preterm delivery with metronidazole and eryt...")
 
Line 20: Line 20:
====Embarazada====
====Embarazada====


<div lang="en" dir="ltr" class="mw-content-ltr">
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 500mg VO Dos veces al día x 7 días<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 500mg PO Twice a day x 7 days<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 250mg VO Tres veces al día también ha sido estudiado<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>
* Aunque el metronidazole cruza la placenta, no se ha reportado evidencia de teratogenicidad o efectos mutagénicos entre los lactantes en múltiples estudios transversales, de casos y controles, y de cohorte de mujeres embarazadas<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
</div>




<div lang="en" dir="ltr" class="mw-content-ltr">
====Profilaxis ([[Special:MyLanguage/Sexual Assault|Agresión Sexual]])====
====Prophylaxis ([[Special:MyLanguage/Sexual Assault|Sexual Assault]])====
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 500mg VO Dos veces al día x 7 días<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>
*[[Special:MyLanguage/Metronidazole|Metronidazole]] 500mg PO Twice a day x 7 days<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>
</div>

Latest revision as of 01:23, 26 January 2026

Other languages:

Tratamiento de Primera Línea[1]

  • Metronidazole 500 mg VO Dos veces al día por 7 días O
  • Metronidazole gel 0,75%, un aplicador completo (5 g) intravaginal, Diario por 5 días O
  • Clindamycin crema 2%, un aplicador completo (5 g) intravaginal Durante la noche por 7 días

El metronidazole no causa una reacción tipo disulfiram con el alcohol.[2]


Régimen Alternativo

  • Clindamycin 300 mg VO BID por 7 días O
  • Clindamycin óvulos 100 mg intravaginales qHS por 3 días (no usar si el paciente ha usado condón de látex en las últimas 72 horas)

Otros regímenes han sido estudiados y tienen eficacia variable comparada con placebo pero debido al costo y disponibilidad no representan alternativas fuera de contraindicaciones absolutas a los regímenes preferidos.



Embarazada

  • Metronidazole 500mg VO Dos veces al día x 7 días[1]
  • Metronidazole 250mg VO Tres veces al día también ha sido estudiado[3][4]
  • Aunque el metronidazole cruza la placenta, no se ha reportado evidencia de teratogenicidad o efectos mutagénicos entre los lactantes en múltiples estudios transversales, de casos y controles, y de cohorte de mujeres embarazadas[1]


Profilaxis (Agresión Sexual)

  1. 1.0 1.1 1.2 CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[1]
  2. Is combining metronidazole and alcohol really hazardous?[2]
  3. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[3]
  4. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[4]
  5. Sexual Assault and Abuse and STIs – Adolescents and Adults[5]